@DrToddLee@ABsteward@BradSpellberg This is fundamentally broken. In superiority studies, alpha is what we look at, but for NI, we need beta to be strong. And physicians are just not well trained to understand beta.
This study is non-informative.
I just had the saddest conversation of my career.
My patient told me that if the next insurance appeal with Sav-Rx, sponsored by @UFCW@UFCWRx is denied that she will pull out her PICC line and choose to die.
Let that sink in. We can cure her, but profit matters more to some.
I just had the saddest conversation of my career.
My patient told me that if the next insurance appeal with Sav-Rx, sponsored by @UFCW@UFCWRx is denied that she will pull out her PICC line and choose to die.
Let that sink in. We can cure her, but profit matters more to some.
@cavecane@UFCW@UFCWRx What is the access to the drug like? A lot of physicians I have worked with have trouble getting Isa in many countries.
Looks like the lowest price internationally is about 41 dollars per capsule. So 82 dollars a day. Cheaper, but still not something a person can afford.
She even attempted to talk to her congressman, @BobOnderMO. We have had luck with other congressional representatives helping us.
We were told that they don't get involved in those kinds of situations.
@IdVilchez@AliSMV7@DrNeilStone 1. It is better than we think.
2. It is becoming resistant to azoles. It's just that in some places it is happening faster than others.